Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo

Honokiol, a natural compound, derived from Magnolia officinalis, has been shown to have anti-cancer effect in several cancer types. However, the underlying molecular mechanism associated with its anti-cancer properties has not been fully elucidated. In the current study, we showed that honokiol inhi...

Full description

Bibliographic Details
Main Authors: Tingting Liu, Hui Liu, Penglei Wang, Yamei Hu, Ran Yang, Fangfang Liu, Hong Gyum Kim, Zigang Dong, Kangdong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2020.603472/full
_version_ 1819206660109893632
author Tingting Liu
Tingting Liu
Hui Liu
Hui Liu
Penglei Wang
Penglei Wang
Yamei Hu
Yamei Hu
Ran Yang
Fangfang Liu
Fangfang Liu
Hong Gyum Kim
Zigang Dong
Zigang Dong
Zigang Dong
Kangdong Liu
Kangdong Liu
Kangdong Liu
Kangdong Liu
Kangdong Liu
author_facet Tingting Liu
Tingting Liu
Hui Liu
Hui Liu
Penglei Wang
Penglei Wang
Yamei Hu
Yamei Hu
Ran Yang
Fangfang Liu
Fangfang Liu
Hong Gyum Kim
Zigang Dong
Zigang Dong
Zigang Dong
Kangdong Liu
Kangdong Liu
Kangdong Liu
Kangdong Liu
Kangdong Liu
author_sort Tingting Liu
collection DOAJ
description Honokiol, a natural compound, derived from Magnolia officinalis, has been shown to have anti-cancer effect in several cancer types. However, the underlying molecular mechanism associated with its anti-cancer properties has not been fully elucidated. In the current study, we showed that honokiol inhibited the growth of melanoma cells in a dose and time-dependent manner. Mechanistically, it directly interacts with keratin 18 (KRT18) protein and induces its degradation through ubiquitination. Furthermore, the expression of KRT18 was found to be higher in melanoma tissues compared to the normal skin tissues. In addition, KRT18 overexpression significantly promoted melanoma cell proliferation and growth. Our results showed that honokiol treatment significantly decreased KRT18 protein level and suppressed the tumor growth in melanoma cell-derived xenograft mice models. Hence, KRT18 plays an oncogenic role in melanoma and honokiol can be an inhibitor for KRT18.
first_indexed 2024-12-23T05:11:07Z
format Article
id doaj.art-02fd30b4ad8a4a9b9c0bdc0cd8512834
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-23T05:11:07Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-02fd30b4ad8a4a9b9c0bdc0cd85128342022-12-21T17:58:58ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-11-01810.3389/fcell.2020.603472603472Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivoTingting Liu0Tingting Liu1Hui Liu2Hui Liu3Penglei Wang4Penglei Wang5Yamei Hu6Yamei Hu7Ran Yang8Fangfang Liu9Fangfang Liu10Hong Gyum Kim11Zigang Dong12Zigang Dong13Zigang Dong14Kangdong Liu15Kangdong Liu16Kangdong Liu17Kangdong Liu18Kangdong Liu19Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaHenan Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, ChinaDepartment of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, ChinaChina-US (Henan) Hormel Cancer Institute, Zhengzhou, ChinaHenan Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, ChinaState Key Laboratory for the Prevention and Treatment of Esophageal Cancer, Zhengzhou University, Zhengzhou, ChinaCancer Chemoprevention International Collaboration Laboratory, Zhengzhou, ChinaHonokiol, a natural compound, derived from Magnolia officinalis, has been shown to have anti-cancer effect in several cancer types. However, the underlying molecular mechanism associated with its anti-cancer properties has not been fully elucidated. In the current study, we showed that honokiol inhibited the growth of melanoma cells in a dose and time-dependent manner. Mechanistically, it directly interacts with keratin 18 (KRT18) protein and induces its degradation through ubiquitination. Furthermore, the expression of KRT18 was found to be higher in melanoma tissues compared to the normal skin tissues. In addition, KRT18 overexpression significantly promoted melanoma cell proliferation and growth. Our results showed that honokiol treatment significantly decreased KRT18 protein level and suppressed the tumor growth in melanoma cell-derived xenograft mice models. Hence, KRT18 plays an oncogenic role in melanoma and honokiol can be an inhibitor for KRT18.https://www.frontiersin.org/articles/10.3389/fcell.2020.603472/fullhonokiolkeratin18degradationubiquitinationmelanoma
spellingShingle Tingting Liu
Tingting Liu
Hui Liu
Hui Liu
Penglei Wang
Penglei Wang
Yamei Hu
Yamei Hu
Ran Yang
Fangfang Liu
Fangfang Liu
Hong Gyum Kim
Zigang Dong
Zigang Dong
Zigang Dong
Kangdong Liu
Kangdong Liu
Kangdong Liu
Kangdong Liu
Kangdong Liu
Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
Frontiers in Cell and Developmental Biology
honokiol
keratin18
degradation
ubiquitination
melanoma
title Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
title_full Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
title_fullStr Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
title_full_unstemmed Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
title_short Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
title_sort honokiol inhibits melanoma growth by targeting keratin 18 in vitro and in vivo
topic honokiol
keratin18
degradation
ubiquitination
melanoma
url https://www.frontiersin.org/articles/10.3389/fcell.2020.603472/full
work_keys_str_mv AT tingtingliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT tingtingliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT huiliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT huiliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT pengleiwang honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT pengleiwang honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT yameihu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT yameihu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT ranyang honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT fangfangliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT fangfangliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT honggyumkim honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT zigangdong honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT zigangdong honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT zigangdong honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT kangdongliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT kangdongliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT kangdongliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT kangdongliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo
AT kangdongliu honokiolinhibitsmelanomagrowthbytargetingkeratin18invitroandinvivo